Drs. Lee Neilson and Miranda Lim Showcase How NAPS Advances RBD and Synucleinopathy Science

Better and faster science in synucleinopathies can bring us closer to neuroprotective clinical trials.

In a recent issue of Current Neurology and Neuroscience Reports, Drs. Lee Neilson and Miranda Lim, NAPS Investigators from Oregon Health Sciences University, review cutting-edge science in REM Sleep Behavior Disorder (RBD) and synucleinopathies.

NAPS participants return annually for similar study procedures. This consistent approach allows investigators to use the collected data or samples to run new tests or analyses on a large cohort as soon as they are available.